OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $127,000 | -59.8% | 60,418 | -5.4% | 0.00% | -50.0% |
| Q2 2015 | $316,000 | -56.5% | 63,892 | -31.2% | 0.00% | -60.0% |
| Q1 2015 | $727,000 | +29.1% | 92,856 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $563,000 | +42.2% | 92,856 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $396,000 | -28.0% | 92,856 | +4.4% | 0.00% | -25.0% |
| Q2 2014 | $550,000 | -4.8% | 88,917 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $578,000 | +34.4% | 88,917 | +16.5% | 0.00% | +33.3% |
| Q4 2013 | $430,000 | -7.1% | 76,333 | +1.3% | 0.00% | -25.0% |
| Q3 2013 | $463,000 | +5.0% | 75,371 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $441,000 | – | 75,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |